ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2026
Muscle performance but not biomechanics associate with second knee injury in a matched cohort of athletes who passed functional return-to-sport criteria after ACL reconstruction.
Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Muscle performance but not biomechanics associate with second knee injury in a matched cohort of athletes who passed functional return-to-sport criteria after ACL reconstruction.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeAthletes remain at risk for a second knee injury after anterior cruciate ligament reconstruction (ACLR), even after passing return-to-sport (RTS) testing. While biomechanical asymmetries have been linked to reinjury, it is unclear whether deficits persist in athletes who meet RTS criteria. This study compared muscle performance and biomechanical function between athletes who sustained a second knee injury after passing RTS testing and matched controls without reinjury.
methodsIn this case-control study, 11 athletes who returned to their preinjury sport within one year after ACLR, passed RTS testing, and subsequently sustained a second knee injury were matched to controls without reinjury. Muscle performance and biomechanical assessments were conducted within two weeks of passing RTS testing, prior to second knee injuries. Muscle performance was assessed using isometric and isokinetic strength testing on an electromechanical dynamometer. Biomechanical function was evaluated during bilateral drop vertical jumps, unilateral drop vertical jumps, and single-legged hop for distance using three-dimensional motion analysis with embedded force platforms. Muscle performance and biomechanical function were compared between limb (injured, uninjured) and group (second knee injury, no second knee injury) using 2 × 2 mixed analyses of variance (ANOVA).
resultsEight athletes reinjured the ipsilateral knee and three injured the contralateral knee, with reinjury occurring on average 15.4 ± 5.0 months after ACLR. Compared with controls, the second injury group showed greater quadriceps rate of torque development symmetry during early isometric contraction (0-100 ms; p = 0.008). No other significant differences in muscle performance or biomechanical variables were observed.
conclusionGreater and more symmetric quadriceps RTD was associated with second knee injury, while biomechanical measures did not differ between groups. These findings suggest that conventional RTS tests may not adequately detect at-risk athletes after ACLR, and broader assessment strategies may be needed to guide targeted injury prevention. LEVEL OF EVIDENCE: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.